Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit
Only One of 44 Attempts to Use the WTO’s “General Exception” to Only One of 44 Attempts to Use the GATT Article XX/GATS Article XIV “General Exception” Has Ever Succeeded Has Ever Succeeded August 19, 2015
Rep. Frank and Rep. Levin Call on Administration to Clarify Position on Capital Controls in TPP May 23, 2012